钠-葡萄糖协同转运蛋白2抑制剂：提升心血管二级预防标准 - Suppr

Sodium-Glucose Cotransporter-2 Inhibitors: Elevating Standards in Cardiovascular Secondary Prevention.

作者信息

Greco Antonio

机构信息

Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico, San Marco", University of Catania, Via Santa Sofia, 78, 95100, Catania, Italy.

出版信息

Am J Cardiovasc Drugs. 2024 Sep;24(5):625-628. doi: 10.1007/s40256-024-00666-0. Epub 2024 Jul 17.

DOI:10.1007/s40256-024-00666-0

PMID:39017985

Abstract

摘要

相似文献

Sodium-Glucose Cotransporter-2 Inhibitors: Elevating Standards in Cardiovascular Secondary Prevention.钠-葡萄糖协同转运蛋白2抑制剂：提升心血管二级预防标准

Am J Cardiovasc Drugs. 2024 Sep;24(5):625-628. doi: 10.1007/s40256-024-00666-0. Epub 2024 Jul 17.

The effect of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 agonists on cardiovascular disease in patients with type 2 diabetes.钠-葡萄糖协同转运蛋白2抑制剂和胰高血糖素样肽1激动剂对2型糖尿病患者心血管疾病的影响。

Clin Cardiol. 2019 Mar;42(3):406-412. doi: 10.1002/clc.23152. Epub 2019 Feb 6.

Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).卡格列净用于心血管事件的一级和二级预防：来自 CANVAS 项目（卡格列净心血管评估研究）的结果。

Circulation. 2018 Jan 23;137(4):323-334. doi: 10.1161/CIRCULATIONAHA.117.032038. Epub 2017 Nov 13.

Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.钠-葡萄糖共转运蛋白 2 抑制剂用于预防 2 型糖尿病患者的心血管事件：系统评价和荟萃分析。

J Am Heart Assoc. 2020 Feb 4;9(3):e014908. doi: 10.1161/JAHA.119.014908. Epub 2020 Jan 29.

Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist.钠葡萄糖协同转运蛋白2抑制剂对心血管结局的类效应：对心血管疾病专科医生的启示

Circulation. 2018 Mar 20;137(12):1218-1220. doi: 10.1161/CIRCULATIONAHA.117.030117.

Cardiovascular and Renal Benefit of Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes.2型糖尿病患者中2型钠-葡萄糖协同转运蛋白抑制剂对心血管和肾脏的益处

Am J Cardiol. 2024 Jul 15;223:183-185. doi: 10.1016/j.amjcard.2024.05.001. Epub 2024 May 9.

Effect of sodium-glucose cotransporter 2 inhibitors on blood pressure in patients with type 2 diabetes and cardiovascular diseases.钠-葡萄糖协同转运蛋白2抑制剂对2型糖尿病合并心血管疾病患者血压的影响。

Hypertens Res. 2024 Sep;47(9):2309-2311. doi: 10.1038/s41440-024-01793-6. Epub 2024 Jul 4.

Cardiorenal protection of sodium-glucose cotransporter 2 inhibitors beyond diabetes: news from the European Society of Cardiology Congress 2020.钠-葡萄糖协同转运蛋白2抑制剂对糖尿病以外疾病的心脏肾脏保护作用：来自2020年欧洲心脏病学会大会的消息

Eur Heart J Cardiovasc Pharmacother. 2020 Nov 1;6(6):341-342. doi: 10.1093/ehjcvp/pvaa114.

Introduction.引言。

Am J Cardiol. 2017 Jul 1;120(1S):S1-S3. doi: 10.1016/j.amjcard.2017.05.008. Epub 2017 May 30.

Assessment of the benefit-risk balance of SGLT2 inhibitors: Commentary on a new 'French paradox'.钠-葡萄糖协同转运蛋白2抑制剂的获益-风险平衡评估：对一种新“法国悖论”的评论

Diabetes Metab. 2019 Sep;45(4):319-321. doi: 10.1016/j.diabet.2019.04.001. Epub 2019 Apr 18.

引用本文的文献

Current and future role of PCSK9 inhibitors in ASCVD prevention.前蛋白转化酶枯草溶菌素9（PCSK9）抑制剂在动脉粥样硬化性心血管疾病（ASCVD）预防中的当前及未来作用

Future Cardiol. 2025 Feb;21(2):71-73. doi: 10.1080/14796678.2025.2450189. Epub 2025 Jan 5.

本文引用的文献

Impact of SGLT2 Inhibitors on Atrial Fibrillation Recurrence after Catheter Ablation in Type 2 Diabetes Mellitus: A Meta-Analysis of Reconstructed Kaplan-Meier Curves with Trial Sequential Analysis.SGLT2 抑制剂对 2 型糖尿病患者导管消融后心房颤动复发的影响：基于试验序贯分析的重建 Kaplan-Meier 曲线的荟萃分析。

Am J Cardiovasc Drugs. 2024 Sep;24(5):629-640. doi: 10.1007/s40256-024-00661-5. Epub 2024 Jul 4.

Trial sequential analysis methodology for interpreting meta-analytical findings.用于解释荟萃分析结果的序贯试验分析方法。

Eur J Intern Med. 2024 Mar;121:1-3. doi: 10.1016/j.ejim.2023.12.029. Epub 2024 Jan 3.

Sodium-glucose co-transporter-2 inhibitors for the prevention of atrial fibrillation: a systemic review and meta-analysis.钠-葡萄糖协同转运蛋白 2 抑制剂预防心房颤动：系统评价和荟萃分析。

Eur J Prev Cardiol. 2024 May 11;31(7):770-779. doi: 10.1093/eurjpc/zwad356.

2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.2023年欧洲心脏病学会糖尿病患者心血管疾病管理指南

Eur Heart J. 2023 Oct 14;44(39):4043-4140. doi: 10.1093/eurheartj/ehad192.

Gender differences in efficacy and safety of antiplatelet strategies for acute coronary syndromes.急性冠状动脉综合征抗血小板治疗策略疗效与安全性的性别差异

Expert Opin Drug Saf. 2023 Jul-Dec;22(8):669-683. doi: 10.1080/14740338.2023.2245331. Epub 2023 Aug 16.

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2023 年 AHA/ACC/ACCP/ASPC/NLA/PCNA 慢性冠状动脉疾病患者管理指南：美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。

Circulation. 2023 Aug 29;148(9):e9-e119. doi: 10.1161/CIR.0000000000001168. Epub 2023 Jul 20.

Gliflozins in the Management of Cardiovascular Disease.格列净类药物在心血管疾病管理中的应用

N Engl J Med. 2022 May 26;386(21):2024-2034. doi: 10.1056/NEJMra2115011.

Repurposing drugs to treat cardiovascular disease in the era of precision medicine.精准医学时代的药物再利用：治疗心血管疾病。

Nat Rev Cardiol. 2022 Nov;19(11):751-764. doi: 10.1038/s41569-022-00717-6. Epub 2022 May 23.

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告

J Am Coll Cardiol. 2022 May 3;79(17):e263-e421. doi: 10.1016/j.jacc.2021.12.012. Epub 2022 Apr 1.

Association of SGLT2 Inhibitors With Risk of Atrial Fibrillation and Stroke in Patients With and Without Type 2 Diabetes: A Systemic Review and Meta-Analysis of Randomized Controlled Trials.SGLT2 抑制剂与伴有和不伴有 2 型糖尿病患者的房颤和卒中风险的关联：一项随机对照试验的系统评价和荟萃分析。

J Cardiovasc Pharmacol. 2022 Feb 1;79(2):e145-e152. doi: 10.1097/FJC.0000000000001183.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Sodium-Glucose Cotransporter-2 Inhibitors: Elevating Standards in Cardiovascular Secondary Prevention.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献